Santiago De Los Caballeros

Researchers are evaluating the safety and effectiveness of the ATC System, a device designed to mechanically remove blood clots and restore blood flow in patients experiencing acute pulmonary embolism (PE). This prospective, single-arm, interventional, multicenter study includes adults aged 18 to 90 with recent symptoms and imaging evidence of PE. The intervention involves using the ATC System to treat participants who meet the clinical criteria. The device works by removing emboli from the pulmonary arteries to improve blood flow. Patients undergo this procedure once as part of the study treatment. Participants will be closely monitored for safety and effectiveness outcomes within 48 hours after the procedure. The main measures include how well the device restores blood flow and the occurrence of any major adverse events related to the device. The study focuses on short-term results immediately following the treatment.